Pathological response to neoadjuvant therapy with chemotherapy vs chemoradiotherapy in stage III NSCLC-contribution of IASLC recommendations

Table 4 Surgery characteristics, n (%)

	RTCh	Ch	P value
	(n = 40)	(n = 27)
No surgery	5 (12.5)	6 (22.2)
Type of surgery			0.48
Lobectomy	21 (60)	16 (76)
Bilobectomy	3 (8.6)	1 (4.8)
Pneumonectomy	2 (5.7)	1 (4.8)
Lobectomy and vascular reconstruction	1 (2.8)	1 (4.8)
Lobectomy and rib resection	5 (14.3)	1 (4.8)
Lobectomy with rib resection and vertebrectomy	3 (8.6)	0
Segmentectomy with rib resection and vertebrectomy	0	1 (4.8)
Node level dissection			0.26
2N2 + 1N1	4 (11.4)	3 (14.3)
3N2	2 (5.7)	5 (23.7)
3N2 + 1N1	12 (34.3)	7 (33.3)
3N2 + 2N1	5 (14.3)	3 (14.3)
4N2 + 1N1	8 (22.9)	1 (4.8)
4N2 + 2N1	0	1 (4.8)
4N2 + 1N3	2 (5.7)	0
5N2 + 1N1	2 (5.7)	1 (4.8)

Ch: Chemotherapy. RTCh: Radiochemotherapy.